DAFNA Capital Management as of Sept. 30, 2019
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 89 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Stereotaxis (STXS) | 18.1 | $48M | 14M | 3.51 | |
| Sage Therapeutics (SAGE) | 6.6 | $18M | 125k | 140.29 | |
| Alder Biopharmaceuticals | 4.5 | $12M | 636k | 18.86 | |
| Blueprint Medicines (BPMC) | 3.4 | $9.1M | 123k | 73.47 | |
| Galapagos Nv- (GLPG) | 3.0 | $8.0M | 53k | 152.66 | |
| AtriCure (ATRC) | 3.0 | $7.9M | 319k | 24.94 | |
| Fate Therapeutics (FATE) | 2.7 | $7.3M | 470k | 15.53 | |
| Cara Therapeutics (CARA) | 2.6 | $6.9M | 379k | 18.28 | |
| iShares NASDAQ Biotechnology Index (IBB) | 2.4 | $6.5M | 65k | 99.51 | |
| Neurocrine Biosciences (NBIX) | 2.2 | $5.8M | 65k | 90.11 | |
| Ascendis Pharma A S (ASND) | 2.2 | $5.8M | 61k | 96.31 | |
| Zogenix | 2.1 | $5.7M | 143k | 40.04 | |
| Aerie Pharmaceuticals | 2.1 | $5.5M | 288k | 19.22 | |
| Dex (DXCM) | 2.0 | $5.4M | 36k | 149.24 | |
| Cytokinetics (CYTK) | 1.8 | $4.8M | 419k | 11.38 | |
| Arena Pharmaceuticals | 1.6 | $4.3M | 94k | 45.77 | |
| Luminex Corporation | 1.6 | $4.2M | 204k | 20.65 | |
| Apellis Pharmaceuticals (APLS) | 1.5 | $4.1M | 170k | 24.09 | |
| Wave Life Sciences (WVE) | 1.5 | $4.1M | 198k | 20.53 | |
| Biohaven Pharmaceutical Holding | 1.5 | $4.0M | 95k | 41.72 | |
| Menlo Therapeutics | 1.4 | $3.8M | 857k | 4.48 | |
| ArQule | 1.4 | $3.8M | 530k | 7.17 | |
| Radius Health Inc note 3.000% 9/0 | 1.4 | $3.7M | 4.0M | 0.92 | |
| Translate Bio | 1.4 | $3.6M | 364k | 9.91 | |
| Akebia Therapeutics (AKBA) | 1.2 | $3.2M | 828k | 3.92 | |
| Xenon Pharmaceuticals (XENE) | 1.1 | $3.0M | 331k | 9.01 | |
| Ardelyx (ARDX) | 1.0 | $2.7M | 581k | 4.70 | |
| Macrogenics (MGNX) | 1.0 | $2.6M | 200k | 12.76 | |
| Argenx Se (ARGX) | 0.9 | $2.5M | 22k | 113.98 | |
| Bluebird Bio (BLUE) | 0.9 | $2.3M | 26k | 91.80 | |
| Kadmon Hldgs | 0.8 | $2.2M | 886k | 2.52 | |
| Cardiovascular Systems | 0.8 | $2.2M | 46k | 47.51 | |
| Alector (ALEC) | 0.8 | $2.1M | 145k | 14.42 | |
| Accuray Incorporated (ARAY) | 0.7 | $1.9M | 674k | 2.77 | |
| Biotelemetry | 0.7 | $1.8M | 45k | 40.73 | |
| Nevro (NVRO) | 0.7 | $1.8M | 21k | 85.95 | |
| Cymabay Therapeutics | 0.7 | $1.8M | 350k | 5.12 | |
| Turning Point Therapeutics I | 0.7 | $1.8M | 47k | 37.60 | |
| Arcturus Therapeutics Hldg I (ARCT) | 0.7 | $1.8M | 174k | 10.27 | |
| Dicerna Pharmaceuticals | 0.6 | $1.7M | 118k | 14.36 | |
| Eloxx Pharmaceuticals | 0.6 | $1.7M | 375k | 4.52 | |
| Achillion Pharmaceuticals | 0.6 | $1.6M | 439k | 3.60 | |
| Kura Oncology (KURA) | 0.6 | $1.6M | 104k | 15.17 | |
| Genocea Biosciences (GNCAQ) | 0.6 | $1.6M | 543k | 2.90 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.6 | $1.5M | 262k | 5.76 | |
| Phasebio Pharmaceuticals | 0.6 | $1.5M | 361k | 4.17 | |
| Applied Genetic Technol Corp C | 0.6 | $1.5M | 359k | 4.16 | |
| Viking Therapeutics (VKTX) | 0.5 | $1.4M | 209k | 6.88 | |
| Corbus Pharmaceuticals Hldgs | 0.5 | $1.4M | 297k | 4.87 | |
| BioCryst Pharmaceuticals (BCRX) | 0.5 | $1.4M | 483k | 2.87 | |
| Natus Medical | 0.5 | $1.4M | 43k | 31.84 | |
| Scynexis | 0.5 | $1.4M | 1.3M | 1.07 | |
| Epizyme | 0.5 | $1.3M | 122k | 10.31 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.5 | $1.2M | 100k | 12.42 | |
| Johnson & Johnson (JNJ) | 0.5 | $1.2M | 9.4k | 129.36 | |
| Gamida Cell | 0.4 | $1.2M | 273k | 4.33 | |
| Inogen (INGN) | 0.4 | $1.1M | 23k | 47.91 | |
| Synlogic | 0.4 | $991k | 433k | 2.29 | |
| Foamix Pharmaceuticals | 0.3 | $929k | 306k | 3.04 | |
| Prevail Therapeutics Ord | 0.3 | $921k | 75k | 12.28 | |
| Bioxcel Therapeutics (BTAI) | 0.3 | $898k | 128k | 7.04 | |
| Neuronetics (STIM) | 0.3 | $883k | 106k | 8.31 | |
| Mersana Therapeutics (MRSN) | 0.3 | $793k | 502k | 1.58 | |
| Cytomx Therapeutics (CTMX) | 0.3 | $738k | 100k | 7.38 | |
| Dermira | 0.2 | $665k | 104k | 6.39 | |
| Sunesis Pharmaceuticals Inc Ne | 0.2 | $663k | 921k | 0.72 | |
| Radius Health | 0.2 | $567k | 22k | 25.77 | |
| Madrigal Pharmaceuticals (MDGL) | 0.2 | $569k | 6.6k | 86.21 | |
| Insmed (INSM) | 0.2 | $529k | 30k | 17.63 | |
| Obseva Sa | 0.2 | $535k | 64k | 8.33 | |
| Assembly Biosciences | 0.2 | $497k | 51k | 9.83 | |
| Masimo Corporation (MASI) | 0.2 | $446k | 3.0k | 148.67 | |
| Spero Therapeutics (SPRO) | 0.2 | $418k | 39k | 10.61 | |
| Gritstone Oncology Ord (GRTS) | 0.2 | $432k | 50k | 8.64 | |
| Dexcom Inc dbcv 0.750% 5/1 | 0.1 | $398k | 250k | 1.59 | |
| Sutro Biopharma (STRO) | 0.1 | $364k | 40k | 9.10 | |
| Urogen Pharma (URGN) | 0.1 | $357k | 15k | 23.80 | |
| Rigel Pharmaceuticals | 0.1 | $295k | 158k | 1.87 | |
| Kalvista Pharmaceuticals (KALV) | 0.1 | $287k | 25k | 11.61 | |
| Aldeyra Therapeutics (ALDX) | 0.1 | $264k | 50k | 5.28 | |
| Zafgen | 0.1 | $226k | 306k | 0.74 | |
| Bellicum Pharma | 0.1 | $210k | 200k | 1.05 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.1 | $199k | 100k | 1.99 | |
| Karuna Therapeutics Ord | 0.1 | $183k | 11k | 16.35 | |
| Evelo Biosciences | 0.1 | $122k | 20k | 6.10 | |
| Advaxis | 0.0 | $95k | 350k | 0.27 | |
| Lineage Cell Therapeutics In (LCTX) | 0.0 | $93k | 95k | 0.98 | |
| Aileron Therapeutics | 0.0 | $67k | 100k | 0.67 | |
| Oramed Pharm (ORMP) | 0.0 | $51k | 16k | 3.19 |
